+91-80-26860424 / 34

Call Us Today

LinkedIn

 

NOVELTY Tag

BananaIP Counsels > Posts tagged "NOVELTY"

Anticipation – Mere Presence of Elements Insufficient; Arrangement of Elements Imperative

This post was first published on July 15, 2014.

 

How is the novelty of an invention established? Another question with a similar connotation is – How does one determine if an invention is anticipated? Simple. Let’s see if something exactly alike exists. Apparently, the district court of the District of Arizona didn’t think so.

We’ll look at a case that will put to rest a lot of doubts surrounding the anticipation of inventions. The case, Net MoneyIN, Inc. v. Verisign, Inc., 545 F.3d 1359 (Fed. Cir. 2008), decided in October 20, 2008, is where the Federal Circuit Court of Appeals clarified the test for anticipation under 35 U.S.C. §102(a).

The patents in contention mainly dealt with subject matter pertaining to systems and methods for online credit card transactions and for addressing security concerns related to these transactions. There were two main issues that were addressed by the inventor – 1. The requirement of prospective customers to send their confidential credit card information to an unknown merchant over the Internet; and

2. Banks that had issued customers’ credit cards imposed stringent requirements on merchants.

Patentability and Section 3(d), History of Patent Law in India, Patentability of Imatinib Masylate in Beta Crystalline Form – Novartis Case Abridged by Dr. Kalyan C. Kankanala

The featured image is the logo of novartis.

This abridged version of the Novartis case was used by Dr. Kalyan C. Kankanala to explain to the students of UPES, the patentability requirements under the Patent Law and the significance of Section 3(d) under the Patents Act. This abridged document was provided to the B.tech - LLB students at UPES School of Law as part of the Patent Law and Practice Program being taught by the BananaIP Team. The Novartis case has been abridged to suit the discussion in the class, and to make it readable for purposes of topics covered. Students are encouraged to read the full decision to learn the history...

Continue reading

Analyzing Patentability of Inventions – A Presentation by Dr. Kalyan C. Kankanala at the UPES School of Law

The featured image is a screen shot of the first slide that forms part of this presentation.

This presentation is part of the 'Patent Law and Practice Program' being taught by BananaIP Team at UPES School of Law to B.tech-LLB Students. This presentation is titled "Analyzing Patentability of Inventions" and covers the following topics: Patentability Requirements Patentable Subject Matter Exclusions Examples Industrial applicability Novelty Inventive Step Secondary Indication Examples Specification Dr. Kalyan's Latest IP Thriller - The Dravidian You may access the full presentation here: [slideshare id=81405702&doc=class2patentabilityrequirementsoverview-171031051706] About Dr. Kalyan C. Kankanala Dr. Kalyan C. Kankanala manages the largest new age Intellectual Property Firm, BananaIP Counsels, headquartered at Bangalore, India. In addition to helping clients maximize business value from intellectual assets, Dr....

Continue reading

Why the Name BananaIP? Why Not?

Why the name BananaIP

"Are you the Bananas?" the client asked, laughing loudly when we entered. "Yes, we are," I said, laughing with her. Almost every one laughs when we introduce ourselves for the first time. "Hi, I am from BananaIP." "Where did you say you are from? Ha Ha Ha" They can't help laughing. One even went to the extent of proclaiming, "Who in the right frame of mind calls an IP firm Banana!" "Me," I said instantly, summoning all my energies to put up a poker face. Laughter again. They laugh, and keep laughing, but never forget. BananaIP is engraved in their memories forever. "Why did a person like you call...

Continue reading

A Presentation on “Patentability Analysis” by Dr. Kalyan C. Kankanala delivered at NLSIU

The featured image read patentability analysis as the post contains a PPT of patentability analysis by Dr. Kalyan C. Kankanala, Cheif IP Attorney , BananaIP Counsels. To read more click here

The following presentation titled “Patentability Analysis”, was delivered on 17th December, 2016 by Dr. Kalyan C. Kankanala, Chief IP Attorney, BananaIP Counsels, at National Law School of India University, Bangalore (NLSIU) to the Post Graduate Diploma Intellectual Property Rights Law PGDIPR students as a part of their course. The Presentation included the following topics: Patentability requirements Patentable Subject Matter Exclusions Section 3(j) Section 3(k) Section 3(i) Industrial Applicability Novelty Inventive Step Secondary Indicia Specification To access the entire presentation please visit the below mentioned link: [slideshare id=70222025&doc=patentabilityanalysis-nls2016-161217053938] About Dr. Kalyan Dr. Kalyan C. Kankanala manages the largest new age Intellectual Property Firm, BananaIP Counsels, headquartered...

Continue reading

Amendments to a PCT Application under Article 19 and Article 34

Characters are pulling a rope written PATENT on top as this article is about Indian Patent Law Basics

In an event where an applicant wishes to make certain changes in only the claims of a direct PCT application, the applicant can invoke the procedure under Article 19. The applicant can only amend the claims under Article 19. The applicant cannot amend the description or the  drawings. There are certain conditions for filing an amendment under this Article. The application must be filed within 2 months from the issuance of the International Search Report and no new matter can be added.  No demand or fees is required to be filed under this Article for the amendments in the claims. It...

Continue reading

Sipping on IP – Conversation on Intellectual Property

Well I am guessing the title of this post may have piqued your interest. ‘Sipping on IP’ is an initiative taken by BananaIP Counsels, where everyone gathers over coffee and lets ideas, discussions and conversations about intellectual property brew. There are no ground rules and the conversation can be about varied topics from more current pressing issues to any IP related concept. It is a great way to connect, take a break and learn from your peers. Let’s see what we sipped on previously. Date: 06/06/2016 Topics discussed: Patent for photography and replicating the building structure, including exteriors and interiors We discussed an interesting piece of...

Continue reading

Patent Law in India- PPT on Patentability Requirements by Dr. Kalyan C. Kankanala at NLSIU

This presentation was delivered by Dr. Kalyan C. Kankanala at NLSIU, Bangalore, India, as a part of the Patent law course offered for PGDIP students. The presentation covers: Introduction to Patentability Requirements and their role in the Patent System in India; The Patent Filter Model; Patentable Subject Matter - Eligible Subjects and Ineligible Subjects; Inventions and Non-Patentable Subject Matter; Section 3 Exclusions with special reference to Section 3(d); Novartis Case - New Form, Known Substance, Known Efficacy; Computer Programs Per Se; Traditional Knowledge and Patentability; Genetic Engineering and Patentability; Life Forms and Patentability; Industrial Applicability - make, use and repeat; ...

Continue reading

Merck v. Glenmark – A Bitter Battle of Pills

  The Delhi High Court has restrained Glenmark from making and marketing generic versions of Merck Sharp & Dohme (MSD)'s popular antidiabetic drug “Januvia” (sitagliptin) and “Janumet” (combination of sitagliptin and metformin) in its latest order dated October 7, 2015. The order restrains Glenmark from making, using, selling, distributing, advertising, exporting, offering for sale or dealing in Sitagliptin Phosphate Monohydrate or any other salt of Sitagliptin in any form, alone or in combination with one or more other drugs or from doing any other thing that infringes the claimed subject matter of MSD’s Indian Patent No. 209816, granted on 6th September,...

Continue reading
css.php
Speak with an IP Expert Today
close slider